Skip to main content
. Author manuscript; available in PMC: 2014 Jan 23.
Published in final edited form as: J Pediatr Endocrinol Metab. 2014 Jan 1;27(0):23–29. doi: 10.1515/jpem-2013-0116

Table 1.

Characteristics of participants with PWS or EMO who stayed on metformin therapy.

PWS (n=14) EMO (n=6)
Age 11.21 (3.81) 11.16 (4.35)
IQ 84.00 (15.60) 90.25 (23.76)
BMI Z-score 1.70 (1.2) 2.59 (0.63)
Glucose fasting, mmol/L 4.87 (0.47) 4.70 (0.07)
Glucose 2 h, mmol/L 6.63 (2.10) 6.1 (1.71)
Insulin fasting 98.13 (51.7) 70.6 (16.3)
Insulin maximum 830.2 (753.7) 603.2 (281.3)

Values are shown as mean (SD).